FDA approves Organon’s VTAMA cream, 1% for the treatment for AD
Organon (OGN) announced that the U.S. Food and Drug Administration or FDA has approved VTAMA or tapinarof cream, 1%, an aryl hydrocarbon receptor agonist, for an additional indication of the topical ...
TheHealthSite15 小时
The Benefits Of Henna Cream Vs Traditional Hair Dye
The main concern related to oxidative permanent colouring is the risk of irritation and allergic reactions. Hair dye residues ...